Omeros Corporation (NASDAQ:OMER) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET
Company Participants
Catherine A. Melfi – Chief Regulatory Officer & VP of Regulatory Affairs and Quality Systems
David J. Borges – VP of Finance, Chief Accounting Officer & Treasurer
Gregory A. Demopulos – Co-Founder, Chairman, CEO & President
Nadia Dac – VP & Chief Commercial Officer
Conference Call Participants
Brandon Richard Folkes – H.C. Wainwright & Co, LLC, Research Division
Olivia Simone Brayer – Cantor Fitzgerald & Co., Research Division
Stephen Gilbertpaul Brozak – WBB Securities, LLC, Research Division
Operator
Good afternoon, and welcome to today’s earnings call for Omeros Corporation. [Operator Instructions] Please be advised this call is being recorded at the company’s request, and a replay will be available on the company’s website 1 week from today. I will now turn the call over to Jennifer Williams, Investor Relations for Omeros.
Unidentified Company Representative
Good afternoon, and thank you for joining us. Before we begin, I’d like to remind you that certain statements made during this call are forward-looking. These statements reflect management’s current beliefs and expectations as of today and are subject to change. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially. For a discussion of these risks and uncertainties, please refer to the special note and the Risk Factors section regarding forward-looking statements in our quarterly report on Form 10-Q filed today with the SEC and the Risk Factors section of our most recent annual report on Form 10-K. With that, I’ll turn the call over to Chairman and CEO of Omeros, Dr. Greg Demopulos.
Gregory A. Demopulos
Thank you, Jennifer, and good afternoon, everyone. Joining me today are David Borges, our Chief Accounting Officer; Nadia Dac, Chief Commercial Officer; Dr. Andreas Grauer, Chief Medical Officer; Dr. Cathy Melfi [Audio Gap].
#Omeros #Corporation #OMER #Earnings #Call #Transcript